Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts

Figure 1

Dulaglutide treatment inhibited diabetes‐induced muscle atrophy. (a) Histopathological image of HE-stained muscles (scale bars: 100 μm and 50 μm). (b) Statistical analysis of the mean cross-sectional area of soleus muscles. (c) RNA was extracted from the soleus muscles, and the mRNA levels of FNDC5 were detected.  < 0.001, comparison between the db/db group and control db/m group; ^# < 0.05, ^## < 0.01, ^#comparison between the dulaglutide-treated group and db/db group.

(a)

(b)

(c)